These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 26968522)

  • 21. Spondylarthropathies in children--are they different from those in adults?
    Hofer M
    Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):315-28. PubMed ID: 16546059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survey of current practices in the management of anti-TNF failure in juvenile spondyloarthritis.
    Srinivasalu H; Oliver M; Stoll ML; Weiss PF; Colbert RA;
    Clin Exp Rheumatol; 2022 Jul; 40(7):1442-1446. PubMed ID: 35485412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on juvenile spondyloarthritis.
    Ramanathan A; Srinivasalu H; Colbert RA
    Rheum Dis Clin North Am; 2013 Nov; 39(4):767-88. PubMed ID: 24182854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment outcome of spondyloarthropathy with infliximab].
    Głowska A; Wiland P; Szechiński J
    Pol Arch Med Wewn; 2005 Jan; 113(1):42-7. PubMed ID: 16130600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Seronegative Spondyloarthropathies.
    Duba AS; Mathew SD
    Prim Care; 2018 Jun; 45(2):271-287. PubMed ID: 29759124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Spondylarthropathies and anti-TNFalpha drugs].
    Pavy S; Allanore Y; Kahan A
    Rev Med Interne; 2005 Sep; 26(9):717-24. PubMed ID: 16154026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.
    Nisar MK; Rafiq A; Östör AJ
    Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of spondyloarthropathy: new pharmacological treatment options.
    Lee RZ; Veale DJ
    Drugs; 2002; 62(16):2349-59. PubMed ID: 12396227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [JUVENILE SPONDYLOARTHRITIS].
    Lamot L; Harjaček M
    Reumatizam; 2016; 63 Suppl 1():59-65. PubMed ID: 29624303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Children With Enthesitis-Related Arthritis and Possible Benefits From Treatments for Adults With Spondyloarthritis.
    Weiss PF; Fuhlbrigge RC; von Scheven E; Lovell DJ; Colbert RA; Brunner HI;
    Arthritis Care Res (Hoboken); 2022 Jul; 74(7):1058-1064. PubMed ID: 33278336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Juvenile spondyloarthropathies: clinical manifestations and medical imaging.
    Azouz EM; Duffy CM
    Skeletal Radiol; 1995 Aug; 24(6):399-408. PubMed ID: 7481895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular features of the HLA-B27-positive seronegative spondyloarthropathies.
    Jhaj G; Kopplin LJ
    Curr Opin Ophthalmol; 2018 Nov; 29(6):552-557. PubMed ID: 30148724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etanercept in spondyloarthropathies. Part I: current evidence of efficacy.
    Palazzi C; D'Angelo S; Cantini F; Lubrano E; Marchesoni A; Mathieu A; Salvarani C; Scarpa R; Spadaro A; Olivieri I
    Clin Exp Rheumatol; 2011; 29(5):858-64. PubMed ID: 22041180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?
    Mitulescu TC; Trandafir M; Dimăncescu MG; Ciuluvică RC; Popescu V; Predețeanu D; Istrate S; Voinea LM
    Rom J Ophthalmol; 2018; 62(2):114-122. PubMed ID: 30206554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding the armamentarium for the spondyloarthropathies.
    Peloso PM; Braun J
    Arthritis Res Ther; 2004; 6 Suppl 2(Suppl 2):S36-43. PubMed ID: 15228620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of biologic agent use in older males with inflammatory diseases: an institution-focused, observational post-marketing study.
    Tran S; Hooker RS; Cipher DJ; Reimold A
    Drugs Aging; 2009; 26(7):607-15. PubMed ID: 19655827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indirect comparisons of the efficacy of subsequent biological agents in patients with psoriatic arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis.
    Ungprasert P; Thongprayoon C; Davis JM
    Clin Rheumatol; 2016 Jul; 35(7):1795-803. PubMed ID: 26852316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biologic therapies in the spondyloarthritis: new opportunities, new challenges.
    Braun J; Brandt J; Listing J; Rudwaleit M; Sieper J
    Curr Opin Rheumatol; 2003 Jul; 15(4):394-407. PubMed ID: 12819466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of familial Mediterranean fever patients concomitant with juvenile spondyloarthropathy.
    Paç Kısaarslan A; Şahin N; Özdemir Çiçek S; Gündüz Z; Poyrazoğlu H; Düşünsel R
    Mod Rheumatol; 2021 May; 31(3):718-724. PubMed ID: 32815445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.